MicroRNA let-7c inhibits migration and invasion of human non-small cell lung cancer by targeting ITGB3 and MAP4K3

Cancer Letters

Volumn 342, Issue 1, 2014, Pages 43-51

  Zhao, Bingtian ^a   Han, Haibo ^a   Chen, Jinfeng ^a   Zhang, Zhiqian ^a   Li, Shaolei ^a   Fang, Fang ^a   Zheng, Qingfeng ^a   Ma, Yuanyuan ^a   Zhang, Jianzhi ^a   Wu, Nan ^a   Yang, Yue ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Let 7c; MicroRNA; Migration and invasion; NSCLC

Indexed keywords

MICRORNA;

3' UNTRANSLATED REGION; ARTICLE; BINDING SITE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER STAGING; CANCER SURVIVAL; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; HUMAN; HUMAN CELL; ITGB3 GENE; LET 7C GENE; LUNG NON SMALL CELL CANCER; MAP4K3 GENE; METASTASIS; METASTASIS POTENTIAL; ONCOGENE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN BINDING;

LET-7C; MICRORNA; MIGRATION AND INVASION; NSCLC;

3' UNTRANSLATED REGIONS; ADENOCARCINOMA; BASE SEQUENCE; BINDING SITES; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTEGRIN BETA3; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; PROTEIN-SERINE-THREONINE KINASES; RNA INTERFERENCE; RNA, MESSENGER;

EID: 84887611561     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.08.030     Document Type: Article

References (37)

1. Jemal A., Center M.M., DeSantis C., Ward E.M. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiology, Biomarkers and Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 2010, 19:1893-1907.
2. Strauss G.M. Adjuvant chemotherapy of lung cancer: methodologic issues and therapeutic advances. Hematology/Oncology Clinics of North America 2005, 19:263-281. vi.
3. Filipowicz W., Bhattacharyya S.N., Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nature Reviews Genetics 2008, 9:102-114.
4. Di Leva G., Croce C.M. Roles of small RNAs in tumor formation. Trends in Molecular Medicine 2010, 16:257-267.
5. Yanaihara N., Caplen N., Bowman E., Seike M., Kumamoto K., Yi M., Stephens R.M., Okamoto A., Yokota J., Tanaka T., Calin G.A., Liu C.G., Croce C.M., Harris C.C. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006, 9:189-198.
6. Arora S., Ranade A.R., Tran N.L., Nasser S., Sridhar S., Korn R.L., Ross J.T., Dhruv H., Foss K.M., Sibenaller Z., Ryken T., Gotway M.B., Kim S., Weiss G.J. MicroRNA-328 is associated with (non-small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration. International Journal of Cancer. Journal International Du Cancer 2011, 129:2621-2631.
7. Chen L.T., Xu S.D., Xu H., Zhang J.F., Ning J.F., Wang S.F. MicroRNA-378 is associated with non-small cell lung cancer brain metastasis by promoting cell migration, invasion and tumor angiogenesis. Medical Oncology 2012, 29:1673-1680.
8. Wang X.C., Tian L.L., Jiang X.Y., Wang Y.Y., Li D.G., She Y., Chang J.H., Meng A.M. The expression and function of miRNA-451 in non-small cell lung cancer. Cancer Letters 2011, 311:203-209.
9. Yang M., Shen H., Qiu C., Ni Y., Wang L., Dong W., Liao Y., Du J. High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer. European Journal Cancer 2012.
10. Liu Z.L., Wang H., Liu J., Wang Z.X. MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN. Molecular and Cellular Biochemistry 2013, 372:35-45.
11. Bussing I., Slack F.J., Grosshans H. Let-7 microRNAs in development, stem cells and cancer. Trends in Molecular Medicine 2008, 14:400-409.
12. Takamizawa J., Konishi H., Yanagisawa K., Tomida S., Osada H., Endoh H., Harano T., Yatabe Y., Nagino M., Nimura Y., Mitsudomi T., Takahashi T. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Research 2004, 64:3753-3756.
13. Esquela-Kerscher A., Trang P., Wiggins J.F., Patrawala L., Cheng A., Ford L., Weidhaas J.B., Brown D., Bader A.G., Slack F.J. The let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle 2008, 7:759-764.
14. Trang P., Wiggins J.F., Daige C.L., Cho C., Omotola M., Brown D., Weidhaas J.B., Bader A.G., Slack F.J. Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice. Molecular Therapy: The Journal of the American Society of Gene Therapy 2011, 19:1116-1122.
15. Kumar M.S., Erkeland S.J., Pester R.E., Chen C.Y., Ebert M.S., Sharp P.A., Jacks T. Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:3903-3908.
16. Fassina A., Cappellesso R., Fassan M. Classification of non-small cell lung carcinoma in transthoracic needle specimens using microRNA expression profiling. Chest 2011, 140:1305-1311.
17. Han H.B., Gu J., Zuo H.J., Chen Z.G., Zhao W., Li M., Ji D.B., Lu Y.Y., Zhang Z.Q. Let-7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer. Journal Pathology 2012, 226:544-555.
18. Bennett J.S., Catella-Lawson F., Rut A.R., Vilaire G., Qi W., Kapoor S.C., Murphy S., FitzGerald G.A. Effect of the Pl(A2) alloantigen on the function of beta(3)-integrins in platelets. Blood 2001, 97:3093-3099.
19. Diener K., Wang X.S., Chen C., Meyer C.F., Keesler G., Zukowski M., Tan T.H., Yao Z. Activation of the c-Jun N-terminal kinase pathway by a novel protein kinase related to human germinal center kinase. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:9687-9692.
20. Leite K.R., Sousa-Canavez J.M., Reis S.T., Tomiyama A.H., Camara-Lopes L.H., Sanudo A., Antunes A.A., Srougi M. Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis. Urologic Oncology 2011, 29:265-269.
21. Nadiminty N., Tummala R., Lou W., Zhu Y., Shi X.B., Zou J.X., Chen H., Zhang J., Chen X., Luo J., deVere White R.W., Kung H.J., Evans C.P., Gao A.C. MicroRNA let-7c is downregulated in prostate cancer and suppresses prostate cancer growth. PloS One 2012, 7:e32832.
22. Pelosi A., Careccia S., Lulli V., Romania P., Marziali G., Testa U., Lavorgna S., Lo-Coco F., Petti M.C., Calabretta B., Levrero M., Piaggio G., Rizzo M.G. miRNA let-7c promotes granulocytic differentiation in acute myeloid leukemia. Oncogene 2012.
23. Sugimura K., Miyata H., Tanaka K., Hamano R., Takahashi T., Kurokawa Y., Yamasaki M., Nakajima K., Takiguchi S., Mori M., Doki Y. Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 2012, 18:5144-5153.
24. Willimott S., Wagner S.D. Stromal cells and CD40 ligand (CD154) alter the miRNome and induce miRNA clusters including, miR-125b/miR-99a/let-7c and miR-17-92 in chronic lymphocytic leukaemia. Leukemia: Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2012, 26:1113-1116.
25. Shimizu S., Takehara T., Hikita H., Kodama T., Miyagi T., Hosui A., Tatsumi T., Ishida H., Noda T., Nagano H., Doki Y., Mori M., Hayashi N. The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma. Journal of Hepatology 2010, 52:698-704.
26. Motoyama K., Inoue H., Nakamura Y., Uetake H., Sugihara K., Mori M. Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 2008, 14:2334-2340.
27. Nadiminty N., Tummala R., Lou W., Zhu Y., Zhang J., Chen X., eVere White R.W., Kung H.J., Evans C.P., Gao A.C. MicroRNA let-7c suppresses androgen receptor expression and activity via regulation of Myc expression in prostate cancer cells. The Journal of Biological Chemistry 2012, 287:1527-1537.
28. Huo Y., Ley K. Adhesion molecules and atherogenesis. Acta Physiologica Scandinavica 2001, 173:35-43.
29. Yoo N.J., Soung Y.H., Lee S.H., Jeong E.G. Mutational analysis of proapoptotic integrin beta 3 cytoplasmic domain in common human cancers. Tumori 2007, 93:281-283.
30. Lei Y., Huang K., Gao C., Lau Q.C., Pan H., Xie K., Li J., Liu R., Zhang T., Xie N., Nai H.S., Wu H., Dong Q., Zhao X., Nice E.C., Huang C., Wei Y. Proteomics identification of ITGB3 as a key regulator in reactive oxygen species-induced migration and invasion of colorectal cancer cells. Molecular and Cellular Proteomics: MCP 2011, 10. (M110 005397).
31. Muller D.W., Bosserhoff A.K. Integrin beta 3 expression is regulated by let-7a miRNA in malignant melanoma. Oncogene 2008, 27:6698-6706.
32. Yu F., Deng H., Yao H., Liu Q., Su F., Song E. Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells. Oncogene 2010, 29:4194-4204.
33. Lam D., Dickens D., Reid E.B., Loh S.H., Moisoi N., Martins L.M. MAP4K3 modulates cell death via the post-transcriptional regulation of BH3-only proteins. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:11978-11983.
34. Hammond D.E., Hyde R., Kratchmarova I., Beynon R.J., Blagoev B., Clague M.J. Quantitative analysis of HGF and EGF-dependent phosphotyrosine signaling networks. Journal of Proteome Research 2010, 9:2734-2742.
35. Findlay G.M., Yan L., Procter J., Mieulet V., Lamb R.F. A MAP4 kinase related to Ste20 is a nutrient-sensitive regulator of mTOR signalling. The Biochemical Journal 2007, 403:13-20.
36. Yan L., Mieulet V., Burgess D., Findlay G.M., Sully K., Procter J., Goris J., Janssens V., Morrice N.A., Lamb R.F. PP2A T61 epsilon is an inhibitor of MAP4K3 in nutrient signaling to mTOR. Molecular Cell 2010, 37:633-642.
37. Marquez-Garban D.C., Mah V., Alavi M., Maresh E.L., Chen H.W., Bagryanova L., Horvath S., Chia D., Garon E., Goodglick L., Pietras R.J. Progesterone and estrogen receptor expression and activity in human non-small cell lung cancer. Steroids 2011, 76:910-920.